Sysmex and bioMerieux Form Commercial Joint Venture for the Japanese In Vitro Diagnostics Market

摘要

Sysmex Corporation and bioMerieux announce that they have signed an agreement by which Sysmex will take a 34% equity stake in bioMerieux Japan Ltd. The new company, called Sysmex bioMerieux Co Ltd will promote and commercialize the entire bioMerieux product range in Japan starting from April 2008. The joint venture will manage the regulatory filing and marketing activities of bioMerieux product ranges in Japan. The sales and customer service activities will be contracted out from the JV to Sysmex.